Kivorent News

Wednesday, November 18, 2026

Health techNews

Kaiser's Northern California doctors group launches Permanentech to build health tech

The Permanente Medical Group, which employs about 10,000 Kaiser Permanente physicians in Northern California, launched Permanentech to turn doctors' ideas into products. Its first company, Wrapt Health, predicts missed appointments across 22 sites.

Docket, covering health regulation and AI in care
, 2 min read

22Northern California sites already using Wrapt Health

What to know

  • The Permanente Medical Group (TPMG) launched Permanentech, a wholly owned subsidiary, at the HLTH conference in Las Vegas on November 16.
  • Permanentech will co-develop, incubate and launch care delivery technology, including AI-enabled tools, with financing and clinical validation for physician-built ideas.
  • Its first portfolio company, Wrapt Health, flags likely missed appointments for outreach and runs at 22 sites with 524 infusion chairs, according to MedCity News.

The Permanente Medical Group (TPMG), the physician group that cares for Kaiser Permanente members in Northern California, has started its own technology company. Permanentech, a wholly owned subsidiary, was announced on November 16 during the HLTH conference in Las Vegas, according to Fierce Healthcare and MedCity News.

The company is meant to turn problems that doctors see on the front line into products, partnerships and stand-alone businesses. Kenneth Trauner, MD, TPMG's chief innovation officer, leads it as CEO.

What Permanentech will do

Fierce Healthcare reported that Permanentech will co-develop, incubate and launch technology for care delivery, with a focus on patient service, access, quality, AI-enabled tools and the cost of delivering care. Physicians with ideas can get financing and help with clinical and operational validation from the concept stage.

The company also plans joint ventures and partnerships with established technology firms. New tools are to start at a few TPMG sites and spread to others once they show results, Fierce reported. More portfolio companies and partnerships are planned in the coming months. No funding figure for Permanentech was disclosed in either report.

The first company: Wrapt Health

Permanentech's first portfolio company is Wrapt Health, which predicts which patients are likely to miss appointments so staff can reach out and fill the slot. MedCity News reported that the idea came from a TPMG oncologist who saw infusion chairs sit empty after cancellations while other patients waited for treatment.

Wrapt looks several days ahead, automates outreach and ranks which cases to work first. It is running in Kaiser Permanente clinics at 22 sites with 524 infusion chairs in Northern California, according to MedCity News. The company says no-show rates are falling but has not published a figure. Elizabeth Boudreau is Wrapt's CEO, and the company plans to offer the tool to other health systems later.

Who is behind it

TPMG is based in Pleasanton, California, and has about 10,000 physicians serving 4.7 million Kaiser Permanente members, along with nearly 47,000 nurses and staff, 203 medical offices and 21 hospitals, Fierce reported. Its parent, Kaiser Permanente, is the largest U.S. nonprofit health system by operating revenue, with $127.7 billion in 2025.

MedCity News compared the model to Health2047, the venture company the American Medical Association launched in 2016 to build businesses from physicians' ideas.

Why it matters

Large health systems usually buy software from outside vendors. A physician group that builds and sells its own tools, starting with a narrow problem like empty infusion chairs, could get products tested on real patients faster, and could put a health system on the selling side of the market. It is the latest of several HLTH launches that move AI into routine care operations, alongside Tom Health's spinout from Lumeris and OpenAI's computer-use agents for health systems. How those tools are validated matters as much as what they promise; see what a randomized controlled trial can and cannot show and CMS's clinical AI roadmap.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

Sources

Digital health and AI in careAI agents

Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.